IP Library Granted Patent US 9,976,170
Granted Patent B2
US 9,976,170 · App. 14/234,875 · Granted May 22, 2018

Method for evaluating bacterial cell wall integrity

Inventors: Jose Luis Fernandez Garcia (Madrid, ES); Jaime Gosalvez Berenguer (Madrid, ES); German Bou Arevalo (Madrid, ES); Maria Tamayo Novas (Madrid, ES); Rebeca Santiso Brandariz (Madrid, ES)
Assignee: UNIVERSIDAD AUTONOMA DE MADRID
C12Q1/18C12Q1/689
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,976,170
App. No.
14/234,875
Granted
May 22, 2018
Kind
B2
Abstract

The present invention relates to a method for evaluating the integrity of the cell wall of the bacteria present in a culture in the presence of an antibiotic acting on the bacterial cell wall which, from a practical point of view, allows quickly determining if a bacterium is sensitive or resistant to an antibiotic acting on the bacterial cell wall. Likewise, the present invention also relates to a lysis solution applicable in the preceding method, specifically affecting bacteria having the cell wall damaged by the action of an antibiotic acting on the bacterial cell wall, which allows distinguishing bacteria sensitive to said antibiotic from those resistant to said antibiotic.

Claims (9)

1. A method for evaluating sensitivity of a bacterium to an antibiotic acting on the bacterial cell wall which comprises:

i) obtaining a pure culture of the bacterium;

ii) adding to said pure culture of said bacterium an antibiotic;

iii) adding a lysis solution to the culture resulting from step ii), the lysis solution comprising 200 mM 2-amino-2-hydroxymethyl-propane-1,3-diol, a pH of 10, 0.05-3 M of NaCl, and either 0.025% sodium dodecylsulfate or 5% 4-(1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol; and

iv) determining the presence of bacterial nucleoid in the culture medium, wherein the presence of bacterial nucleoid in the culture medium is indicative that the bacterium is sensitive to the antibiotic.

2. The method according to claim 1 , wherein the presence of the bacterial nucleoid in the culture medium is carried out by means of staining.

3. The method according to claim 2 , wherein the staining is carried out by means of using one or more fluorochromes.

4. The method according to claim 1 , wherein the antibiotic is selected from the group consisting of a β-lactam antibiotic, an isoniazid, an ethionamide, an ethambutol, a cycloserine and a glycopeptide antibiotic.

5. The method according to claim 1 , wherein the method comprises step v, before or after step (iii), of immobilizing a sample from the culture on a slide.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE LAST NAME OF THE SECOND ASSIGNOR PREVIOUSLY RECORDED ON REEL 032042 FRAME 0161. ASSIGNOR(S) HEREBY CONFIRMS THE THE LAST NAME OF THE SECOND ASSIGNOR IS GOSALVEZ BERENGUER, JAIME. Recorded Apr 7, 2014
From: FERNANDEZ GARCIA, JOSE LUIS; GOSALVEZ BERENGUER, JAIME; BOU AREVALO, GERMAN; TAMAYO NOVAS, MARIA; SANTISO BRANDARIZ, REBECA
To: UNIVERSIDAD AUTONOMA DE MADRID
Reel/Frame 032621/0914 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2014
From: FERNANDEZ GARCIA, JOSE LUIS; GOSALVES BERENGUER, JAIME; BOU AREVALO, GERMAN; TAMAYO NOVAS, MARIA; SANTISO BRANDARIZ, REBECA
To: UNIVERSIDAD AUTONOMA DE MADRID
Reel/Frame 032042/0161 →
Priority Claims (1)
ES 201131276 · Jul 26, 2011 · national
Continuity (1)
Related Publication 20140206573A1 · Jul 24, 2014